Evidence map›Paper›PMID 41676334›Full record

ArticleClinical & translational immunology2026

CD56

Griffith B Perkins, Christopher M Hope, Cheng Sheng Chai, Matthew J Tunbridge, Sebastian Sterling, Kevin Webb, Joey Yap, Arthur Eng Lip Yeow, Makutiro G Masavuli, Jacqueline Scaffidi and 12 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical & translational immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Griffith B PerkinsCentral and Northern Adelaide Renal and Transplantation Service Royal Adelaide Hospital Adelaide SA Australia.ORCID https://orcid.org/0000-0001-8559-5872
Christopher M HopeSchool of Medicine Adelaide University Adelaide SA Australia.
Cheng Sheng ChaiSchool of Medicine Adelaide University Adelaide SA Australia.
Matthew J TunbridgeCentral and Northern Adelaide Renal and Transplantation Service Royal Adelaide Hospital Adelaide SA Australia.
Sebastian SterlingSchool of Medicine Adelaide University Adelaide SA Australia.ORCID https://orcid.org/0000-0001-8567-7042
Kevin WebbDepartment of Neurology Royal Adelaide Hospital Adelaide SA Australia.
Joey YapCentral Adelaide Local Health Network Adelaide SA Australia.
Arthur Eng Lip YeowSchool of Medicine Adelaide University Adelaide SA Australia.
Makutiro G MasavuliSchool of Medicine Adelaide University Adelaide SA Australia.
Jacqueline ScaffidiSchool of Medicine Adelaide University Adelaide SA Australia.
James D ZuianiSchool of Medicine Adelaide University Adelaide SA Australia.
Anouschka AkermanKirby Institute University of New South Wales Sydney NSW Australia.
Anupriya AggarwalKirby Institute University of New South Wales Sydney NSW Australia.
Vanessa MilogiannakisKirby Institute University of New South Wales Sydney NSW Australia.
Matthew B RobertsInfectious Diseases Royal Adelaide Hospital Adelaide SA Australia.ORCID https://orcid.org/0000-0003-0869-6463
Plinio R HurtadoCentral and Northern Adelaide Renal and Transplantation Service Royal Adelaide Hospital Adelaide SA Australia.
Stuart TurvilleKirby Institute University of New South Wales Sydney NSW Australia.
Branka Grubor-BaukSchool of Medicine Adelaide University Adelaide SA Australia.
Simon C BarrySchool of Medicine Adelaide University Adelaide SA Australia.
Janakan RavindranDepartment of Neurology Royal Adelaide Hospital Adelaide SA Australia.
Patrick Toby CoatesCentral and Northern Adelaide Renal and Transplantation Service Royal Adelaide Hospital Adelaide SA Australia.
Pravin HissariaSchool of Medicine Adelaide University Adelaide SA Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: We sought to identify determinants of vaccine response in people with multiple sclerosis (pwMS) receiving B-cell-depleting therapies. Methods: This was a prospective single-centre cohort study (ACTRN12623001249640). Peripheral blood samples were collected from pwMS receiving ocrelizumab ( Results: CD20 Conclusion: Time since ocrelizumab infusion was not associated with protective vaccination. Evaluation of B-cell and CD56

Indexed as

B‐cell depletionCD56bright NK cellsmultiple sclerosisvaccinationvirus neutralisation

Identifiers

PMID41676334
PMCPMC12887676

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.